Navigation Links
NUCRYST and Smith & Nephew Revise Agreements
Date:10/1/2007

ing and obtain new regulatory approvals for any future products we may develop; we may not be able to establish successful commercialization programs, through new corporate collaborations or otherwise, for our future products; competition from other silver-based pharmaceutical or medical device companies; our ability to raise additional financing required to fund further research and development, clinical studies and obtain regulatory approvals, on commercially acceptable terms or at all; changes in currency exchange rates; our ability to protect our intellectual property rights and to not infringe on the intellectual property rights of others; our ability to comply with governmental regulations and standards; our ability to successfully attract and retain skilled and experienced personnel; changes in general economic and capital market conditions; other risks and uncertainties unidentified at this time; and management's response to these factors.

Although we have attempted to identify the important risks, uncertainties and other factors that could cause actual results or events to differ materially from those expressed or implied in forward-looking statements, there may be other factors that cause actual results or events to differ from those expressed or implied in forward looking statements. For a more thorough discussion of the risks associated with our business, see the "Risk Factors" section in our Annual Report on Form 10-K for the year ended December 31, 2006, filed with the U.S. Securities and Exchange Commission on EDGAR at http://www.sec.gov and with securities authorities in Canada on SEDAR at http://www.sedar.com. All forward-looking statements are expressly qualified in their entirety by this cautionary statement and NUCRYST disclaims any intention or obligation to revise or update any forward-looking statements whether as a result of new information,
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. Iodex goes to SmithKline Beecham consumer Healthcare
3. GlaxoSmithKline To Cultivate Non-Smoking Environment
4. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
5. FDA Mislead On Asthma Drug By GlaxoSmithKline
6. GlaxoSmithKline Defends Its Products
7. GlaxoSmithKline launches diabetes and cancer drugs
8. Generic Products Compete With GlaxoSmithKline
9. New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline
10. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
11. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Buffers that guard against damage to the ends of chromosomes ... melanoma the deadliest form of skin cancer according ... The study has uncovered an important new genetic risk factor ... mole count are the strongest indicators of those most at ... more care in the sun, as they burn more easily. ...
(Date:9/17/2014)... Chicago IL (PRWEB) September 17, 2014 ... of Pseudomonas aeruginosa infections allegedly caused by Non-Sterile ... to learn more about their options for legal recourse. ... & Drug Administration (FDA) in March 2012, after the ... Pseudomonas aeruginosa at William Beaumont Hospital in Royal Oak, ...
(Date:9/17/2014)... NY (PRWEB) September 17, 2014 In ... acknowledges that “bi-weekly telephonic discovery conferences would be beneficial ... such conferences through mid-December. “At the end of December,” ... assess the need for additional conferences. , “The ... recognizes that there is still much to be discussed ...
(Date:9/17/2014)... News, VA (PRWEB) September 17, 2014 ... will host recruit757’s scholarship workshop for football players ... on Tuesday, Sept. 23. , Doors open at 6:30 ... Performance Center and speak to trainers and physical therapists. ... until 9 p.m. , The Newport News Tidewater Performance ...
(Date:9/17/2014)... 2014 (HealthDay News) -- A blood test that measures ... with a better assessment of the state of a ... used routinely, this blood test could reveal when ... begins promoting tumor growth, the researchers suggested. "Our ... with advanced prostate cancer and often initially very effective ...
Breaking Medicine News(10 mins):Health News:Chromosome buffers hold key to better melanoma understanding 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:Transvaginal Mesh Lawsuit News: New Order in C.R. Bard MDL Sets Schedule of Conferences for September to December, the Rottenstein Law Group LLP Reports 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2
... Pancreatic cancer develops and spreads much more slowly than ... Hopkins investigators. The finding indicates that there is a ... disease. "For the first time, we have a ... when it would be best to intervene," according to ...
... tumors are one of the most lethal cancers, with fewer ... But a new study that peers deeply into the genetics ... opportunity for early diagnosis. In contrast to earlier predictions, many ... years to become lethal after the first genetic perturbations appear. ...
... PHILADELPHIA Demetrius H. Bagley, M.D., the Nathan Lewis Hatfield ... Medical College (JMC) of Thomas Jefferson University was recently honored ... Award in Endourology at the World Congress of Endourology. ... is fitting that Dr. Bagley was chosen to receive the ...
... News) --Mental health issues confronted by U.S. veterans returning ... by gender, new research suggests. Female veterans ... than are their male counterparts, according to a study ... the Veterans Administration from 2002 to 2008. They are ...
... efficient as humans mature. Now, for the first time ... Polytechnique Fdrale de Lausanne (EPFL) and the University of ... verified these gains with a powerful new computer program. ... the soon-to-be-released software allows for individualized maps of vital ...
... and University of North Carolina (UNC) researchers report in ... that narcotics and diagnostic testing are overused in ... overlook more effective treatments for neck pain, such as ... evidence to support the effectiveness of therapeutic exercise in ...
Cached Medicine News:Health News:Surprise finding: Pancreatic cancers progress to lethal stage slowly 2Health News:Surprise finding: Pancreatic cancers progress to lethal stage slowly 3Health News:Revising the timeline for deadly pancreatic cancer 2Health News:Revising the timeline for deadly pancreatic cancer 3Health News:Jefferson urologist awarded Lifetime Achievement Award from Endourological Society 2Health News:Mental Health Issues Differ for U.S. Male, Female Vets 2Health News:The brain's journey from early Internet to modern-day fiber optics -- all in 1 lifetime 2Health News:Narcotics and diagnostics overused in treatment of chronic neck pain 2
(Date:9/17/2014)... , Sept. 17, 2014   OTEMR, Inc. , ... Complete EHR certification, which designates that the software is ... 1 and Stage 2 Meaningful Use measures required to ... Act (ARRA).  ONETOUCH EMR 2.0 was certified on July ... of the National Coordinator-Authorized Certification Body (ONC-ACB) and is ...
(Date:9/17/2014)... , Sept. 17, 2014  Millions of people suffer from ... disease. Recently the FDA approved the launch ... an innovative implant device developed by Spinal Kinetics, which may ... neck and or arm pain. Hospital for Special Surgery (HSS), ... only hospital in New York City ...
(Date:9/17/2014)... , Sept. 17, 2014   MedeAnalytics ... solution that brings complete visibility to a provider,s ... an ever-evolving reimbursement landscape. Powered by the industry,s ... to the critical point between patient access and ... The solution will improve revenue capture, minimize audit ...
Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3
... on 11 Patients at SAWCPRINCETON, N.J., April 29 ... (OTC Bulletin Board: DSCI), a provider of advanced wound ... the Advances in Wound Care (SAWC) in Dallas, Jason R. ... Florida, revealed details of a recently concluded 11-patient venous leg ...
... to Cover Therapeutic Delivery Across Blood-Brain BarrierNOVATO, Calif., ... ("Raptor" or the "Company") (OTC Bulletin Board: RPTP) ... Trademark Office ("USPTO") has issued two Notices of ... 11/202,566, titled " Methods of increasing delivery of ...
Cached Medicine Technology:Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 2Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 3Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications 2Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications 3Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications 4Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications 5
This 100 µL is the equivalent to the "Universal Blue" tips and fits virtually every manufacturer's 1000 µL Pipettor....
Conducting disposable tips provide cross-contaminationfree pipetting for sensitive applications such as PCR setup....
Volume range 0.2-10 l. Designed for pipetting micro-sized drops. Ideal for use with micro volume Finnpipettes....
Conducting disposable tips....
Medicine Products: